dc.contributor.author | Rudran, B | en_US |
dc.contributor.author | Reader, C | en_US |
dc.contributor.author | Foster, J | en_US |
dc.contributor.author | Hodivala-Dilke, K | en_US |
dc.contributor.author | Sosabowski, J | en_US |
dc.contributor.author | Marshall, J | en_US |
dc.date.accessioned | 2020-08-17T13:57:28Z | |
dc.date.issued | 2018 | en_US |
dc.identifier.issn | 1556-0864 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/66345 | |
dc.format.extent | S518 - S519 | en_US |
dc.language.iso | en | en_US |
dc.subject | integrin alpha-v-beta-6 | en_US |
dc.subject | treatment | en_US |
dc.subject | Antibody | en_US |
dc.title | Antibody Blockade of Integrin Alpha-V-Beta-6 (avb6) as a Novel Treatment for NSCLC | en_US |
dc.type | Conference Proceeding | |
dc.identifier.doi | 10.1016/j.jtho.2018.08.700 | en_US |
pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000454014501333&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 10 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 13 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |
qmul.funder | The role of αvβ6 in lung cancer::Rosetrees Trust | en_US |
qmul.funder | The role of αvβ6 in lung cancer::Rosetrees Trust | en_US |